StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.28+0.03 (+2.40%)

Close on Nov 17, 2026Market cap $97.53MP/E –Yield –

Earnings

Neuronetics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 16, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$42.00M
+12.6% on a year earlier
EPS, Q3 FY2026
-$0.02
-$0.13 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of Neuronetics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026before the open$42.00M+12.6%-$0.02Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026before the open$41.60M+9.2%-$0.05Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$34.50M+7.8%–Release
Q4 FY2025ended Dec 31, 2025Mar 17, 2026before the open$41.80M+85.8%-$0.10Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open$37.30M+101.6%-$0.13Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$38.10M+130.9%-$0.15Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open$32.00M+83.9%-$0.21Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025before the open$22.50M+10.8%-$0.33Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$18.50M+3.4%-$0.44Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open$16.50M-6.3%-$0.33Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$17.40M+12.3%-$0.27Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Neuronetics's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenueGAAPFY2026$160.00M – $164.00M–NewNov 4, 2026
Total revenueFY2026$160.00M – $164.00M$160.00M – $166.00MLoweredAug 11, 2026
Total RevenueFY2026$160.00M – $166.00M–NewMar 17, 2026
Gross marginGAAPFY202649% – 50%–NewNov 4, 2026
Gross marginFY202648% – 50%47% – 49%RaisedAug 11, 2026
Gross MarginFY202647% – 49%–NewMar 17, 2026
Cash flow from operating and investingFY2026-$12.00M – -$10.00M–NewNov 4, 2026
Cash flow from operationsFY2026-$17.00M – -$13.00M–LoweredMay 5, 2026
Cash flow from operations and investingFY2026-$14.50M – -$10.50M–RaisedAug 11, 2026
Operating Cash FlowFY2026-$17.00M – -$13.00M–LoweredMar 17, 2026
Operating expensesGAAPFY2026$92.50M – $95.50M–NewNov 4, 2026
Operating expensesGAAPFY2026$95.00M – $100.00M–NewAug 11, 2026
Operating expensesnon-GAAPFY2026$91.00M – $96.00M–NewAug 11, 2026
Operating expensesFY2026$100.00M – $105.00M–NewMay 5, 2026
Operating ExpensesFY2026$100.00M – $105.00M–NewMar 17, 2026
Operating expenses, excluding stock-based compensationnon-GAAPFY2026$89.00M – $92.00M–NewNov 4, 2026

Guidance vs results

The last range Neuronetics gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q1 FY2026Revenue$33.00M – $35.00M$34.50MWithin range
FY2025Revenue$147.00M – $150.00M$149.20MΣ4QWithin range
Q4 FY2025Revenue$40.00M – $43.00M$41.80MWithin range
Q3 FY2025Revenue$37.00M – $39.00M$37.30MWithin range
Q2 FY2025Revenue$36.00M – $38.00M$38.10MAbove range
Q1 FY2025Revenue$28.00M – $30.00M$32.00MAbove range
Q4 FY2024Revenue$19.00M – $20.00M$22.50MAbove range
Q3 FY2024Revenue$18.50M – $19.50M$18.50MWithin range
Q2 FY2024Revenue$18.00M – $19.00M$16.50MBelow range
Q1 FY2024Revenue$16.70M – $17.70M$17.40MWithin range
Q4 FY2023Revenue$19.00M – $21.00M$20.30MWithin range
Q3 FY2023Revenue$17.00M – $18.00M$17.90MWithin range

Guidance history

Every forecast Neuronetics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Cash flow from operating and investingFY2026-$12.00M – -$10.00MNew
Nov 4, 2026Gross marginFY202649% – 50%New
Nov 4, 2026Operating expensesFY2026$92.50M – $95.50MNew
Nov 4, 2026Operating expenses, excluding stock-based compensationFY2026$89.00M – $92.00MNew
Nov 4, 2026Total revenueFY2026$160.00M – $164.00MNew
Aug 11, 2026Gross marginFY202648% – 50%Raised
Aug 11, 2026Cash flow from operations and investingFY2026-$14.50M – -$10.50MRaised
Aug 11, 2026Operating expensesFY2026$95.00M – $100.00MNew
Aug 11, 2026Operating expensesFY2026$91.00M – $96.00MNew
Aug 11, 2026Total revenueFY2026$160.00M – $164.00MLowered
May 5, 2026Gross marginFY202647% – 49%New
May 5, 2026Operating expensesFY2026$100.00M – $105.00MNew
May 5, 2026Cash flow from operationsFY2026-$17.00M – -$13.00MLowered
May 5, 2026Total revenueFY2026$160.00M – $166.00MNew
Mar 17, 2026Gross MarginFY202647% – 49%New
Mar 17, 2026Operating ExpensesFY2026$100.00M – $105.00MNew
Mar 17, 2026Operating Cash FlowFY2026-$17.00M – -$13.00MLowered
Mar 17, 2026total worldwide revenueQ1 FY2026$33.00M – $35.00MNew
Mar 17, 2026Total RevenueFY2026$160.00M – $166.00MNew
Nov 4, 2025gross marginFY202547% – 49%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Neuronetics filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. Results
  4. Results
  5. Results
  6. Results
  7. Update
  8. Results
  9. Results
  10. Update
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?